Dewey Steadman | Head-Investor Relations |
Martine Rothblatt | Chairperson and Chief Executive Officer |
Michael Benkowitz | President and Chief Operating Officer |
James Edgemond | Chief Financial Officer and Treasurer |
Leigh Peterson | Senior Vice President of Product Development |
Pat Poisson | Executive Vice President of Technical Operations |
Jessica Fye | JPMorgan |
Justin Phillips | Morgan Stanley |
Hartaj Singh | Oppenheimer & Co. |
Ashwani Verma | UBS |
Joseph Thome | Cowen and Company |
Andreas Argyrides | Wedbush Securities |
Good morning and welcome to the United Therapeutics Corporation Fourth Quarter and Full Year 2022 Earnings Webcast. My name is Devin, and I will be your conference operator today. [Operator Instructions]
I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Thanks, Devin, and good morning.